ORIC Pharmaceuticals names general counsel

ORIC Pharmaceuticals, a privately held, clinical-stage oncology company, announced Dr. Christian Kuhlen has been named general counsel.

THIS IS MEMBERS-ONLY CONTENT

SINGLE MEMBERSHIP                                             CORPORATE MEMBERSHIP

You are not logged in and do not have access to members-only content.

If you are already a registered user or a member, SIGN IN now.